首页 | 本学科首页   官方微博 | 高级检索  
检索        

NP与EP方案治疗晚期非小细胞肺癌的比较
引用本文:巴宁,董晓丽,庄振利,徐向东.NP与EP方案治疗晚期非小细胞肺癌的比较[J].中华肿瘤防治杂志,2005,12(17):1337-1338.
作者姓名:巴宁  董晓丽  庄振利  徐向东
作者单位:莱阳中心医院胸外科山东莱阳265200
摘    要:为观察比较长春瑞滨(NVB)联合顺铂(DDP)组成的NP方案与依托泊苷(Vp16)联合DDP组成的EP方案,治疗晚期非小细胞肺癌(nonsmall cell lung cancer,NSCLC)的疗效和毒性反应,选取82例晚期NSCLC患者,随机分为NP和EP两组进行化疗。结果示,NP组有效率为52.5%(21/40),EP组有效率为28.6%(12/42),NP组疗效优于EP组,但差异尚无统计学意义,u=1.855,P=0.064。两组剂量限制毒性均为骨髓抑制,消化道反应可以耐受。初步研究结果提示,NP方案治疗晚期NSCLC的疗效高于EP方案。

关 键 词:  非小细胞肺/药物疗法  长春碱  依托泊苷  顺铂  抗肿瘤药  多剂联用
文章编号:1009-4571(2005)17-1337-02
修稿时间:2005年2月25日

Comparative study of NP and EP regimen in advanced non-small cell lung cancer
BA Ning,DONG Xiao-li,ZHUANG Zhen-li,XU Xiang-dong.Comparative study of NP and EP regimen in advanced non-small cell lung cancer[J].Chinese Journal of Cancer Prevention and Treatment,2005,12(17):1337-1338.
Authors:BA Ning  DONG Xiao-li  ZHUANG Zhen-li  XU Xiang-dong
Institution:BA Ning,DONG Xiao-li,ZHUANG Zhen-li,XU Xiang-dong Department of Thoracic Surgery,Laiyang Central Hospital Yantai Shandong,Laiyang 265200,P.R.China
Abstract:The objective of this study was to evaluate and compare the effect and side-effect of NP(NVB+DDP)regimen and EP(Vp-16+DDP)regimen for advanced non-small cell lung cancer (NSCLC). Eighty-two cases of advanced NSCLC were randomly divided into NP regimen group and EP regimen group. The results showed that the response rates of NP group and EP group were 52.5%(21/40) and 28.6%(12/42),respectively. The difference between them is not significant,u=1.855, P=0.064. The dose limiting toxicity was neutropenia,and gastric irritation was tolerable. In conclusion, in the treatment of advanced NSCLC, the efficacy of NP regimen is better than EP regimen.
Keywords:carcinoma  non-small cell lung/drug therapy  vinblastine  etoposide  cisplatin  antineoplastic agents  combined
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号